Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit

被引:58
作者
Shi, Jingyi [1 ]
Sun, Ting [1 ]
Cui, Yun [1 ]
Wang, Chunxia [1 ,2 ]
Wang, Fei [1 ]
Zhou, Yiping [1 ]
Miao, Huijie [1 ]
Shan, Yijun [1 ]
Zhang, Yucai [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Crit Care Med, Shanghai 20062, Peoples R China
[2] Shanghai Jiao Tong Univ, Inst Pediat Crit Care, Shanghai 20062, Peoples R China
[3] Shanghai Jiao Tong Univ, Childrens Hosp, Dept Crit Care Med, 355 Luding Rd, Shanghai 200062, Peoples R China
关键词
MDR/XDR; Acinetobacter baumannii; Risk factors; Mortality; Pediatric intensive care units; IN-VITRO ACTIVITIES; T-CELLS; CARBAPENEMS; COMBINATION; TIGECYCLINE; POLYMYXINS; EMERGENCE; SYNERGY; HEALTH;
D O I
10.1186/s12879-020-05321-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Multidrug resistant (MDR) and extensively drug resistant (XDR)Acinetobacter baumanniipresents challenges for clinical treatment and causes high mortality in children. We aimed to assess the risk factors and overall mortality for MDR/XDRAcinetobacter baumanniiinfected pediatric patients. Methods: This retrospective study included 102 pediatric patients who developed MDR/XDRAcinetobacter baumanniiinfection in the pediatric intensive care unit (PICU) of Shanghai Children's Hospital in China from December 2014 to May 2018. Acinetobacter baumanniiclinical isolates were recovered from different specimens including blood, sputum, bronchoalveolar lavage fluid, cerebrospinal fluid, ascites, hydrothorax, and urine. Antibiotic susceptibility test was determined according to the Clinical and Laboratory Standards Institute interpretive criteria. Clinical and biological data were obtained from the patients' medical records. Results: 102 patients withAcinetobacter baumanniiinfection were enrolled. The median age was 36 (9.6, 98.8) months, and there were 63 male in the case group. The overall mortality rate was 29.4%, while theAcinetobacter baumannii-associated mortality rate was 16.7% (17/102, 12 bloodstream infections, 4 meningitis and 1 intra-abdominal infection). Bloodstream infections occurred in 28 patients (27.5%), and 10 patients (9.8%) among them had central line-associated bloodstream infections (6 central venous catheters, 2 PICCs, 1 venous infusion port and 1 arterial catheter). Cerebrospinal fluid (CSF) cultures were positive in 4(3.9%) patients. 14(13.7%) patients got positive cultures in ascites and hydrothorax. Lower respiratory isolates (56/102) accounted for 54.9% of all patients. Non-survival patients appeared to have a lower NK cell activity (6.2% +/- 3.61% vs. 9.15% +/- 6.21%,P = 0.029), higher CD4+ T cell ratio (39.67% +/- 12.18% vs. 32.66% +/- 11.44%,P = 0.039),and a higher serum level of interlukin-8 (IL-8, 15.25 (1.62, 47.22)pg/mL vs. 0.1 (0.1, 22.99)pg/mL,P = 0.01) whenAcinetobacter baumanniiinfection developed. Multivariate logistic analysis indicated that high serum level of Cr (RR, 0.934, 95%CI, 0.890-0.981;P = 0.007) and high BUN/ALB level (RR, 107.893, 95%CI, 1.425-870.574;p = 0.005) were associated with high risk of mortality in MDR/XDRAcinetobacter baumanniiinfected patients. Conclusion: MDR/XDRAcinetobacter baumanniiinfection is a serious concern in pediatric patients with high mortality. Bloodstream and central nervous system infection accounted for high risk of death. Acute kidney injury is associated with high risk of mortality.
引用
收藏
页数:9
相关论文
共 33 条
[1]  
Ayobami Olaniyi, 2019, Emerg Microbes Infect, V8, P1747, DOI 10.1080/22221751.2019.1698273
[2]  
Cai XF, 2012, WORLD J EMERG MED, V3, P202, DOI [10.5847/wjem.j.issn.1920-8642.2012.03.008, 10.5847/wjem.j.1920-8642.2012.03.008]
[3]   Risk Factors for Mortality in Children with Acinetobacter baumannii Bacteremia in South Korea: The Role of Carbapenem Resistance [J].
Choe, Young June ;
Lee, Hoan Jong ;
Choi, Eun Hwa .
MICROBIAL DRUG RESISTANCE, 2019, 25 (08) :1210-1218
[4]   Elevated Blood Urea Nitrogen-to-Serum Albumin Ratio as a Factor That Negatively Affects the Mortality of Patients with Hospital-Acquired Pneumonia [J].
Feng, Ding-Yun ;
Zhou, Yu-Qi ;
Zou, Xiao-Ling ;
Zhou, Mi ;
Yang, Hai-Ling ;
Chen, Xiao-Xia ;
Zhang, Tian-Tuo .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2019, 2019
[5]   Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia [J].
Freire, M. P. ;
de Oliveira Garcia, D. ;
Garcia, C. P. ;
Campagnari Bueno, M. F. ;
Camargo, C. H. ;
Kono Magri, A. S. G. ;
Francisco, G. R. ;
Reghini, R. ;
Vieira, M. F. ;
Ibrahim, K. Y. ;
Rossi, F. ;
Hajjar, L. ;
Levin, A. S. ;
Hoff, P. M. ;
Pierrotti, L. C. ;
Abdala, E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (04) :352-358
[6]   Resistance Rates of Intra-Abdominal Isolates from Intensive Care Units and Non-Intensive Care Units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010-2012 [J].
Hackel, Meredith A. ;
Badal, Robert E. ;
Bouchillon, Samuel K. ;
Biedenbach, Douglas J. ;
Hoban, Daryl J. .
SURGICAL INFECTIONS, 2015, 16 (03) :298-304
[7]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[8]   In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with β-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains [J].
Higgins, PG ;
Wisplinghoff, H ;
Stefanik, D ;
Seifert, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1586-1592
[9]   CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting [J].
Horan, Teresa C. ;
Andrus, Mary ;
Dudeck, Margaret A. .
AMERICAN JOURNAL OF INFECTION CONTROL, 2008, 36 (05) :309-332
[10]   Implications for paediatric shock management in resource-limited settings: a perspective from the FEAST trial [J].
Houston, Kirsty Anne ;
George, Elizabeth C. ;
Maitland, Kathryn .
CRITICAL CARE, 2018, 22